Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|May 26, 2006
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalisTatiana Bogdanovich, Catherine Clark, Lois Ednie, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2008
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibioticsSandrine Lemaire, Aurélie Olivier, Françoise Van Bambeke, et al.
Drugs|November 7, 2007
Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic optionsFrançoise Van Bambeke, René R Reinert, Peter C Appelbaum, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 6, 2002
Maxillary sinus puncture and culture in the diagnosis of acute rhinosinusitis: the case for pursuing alternative culture methodsMichael S Benninger, Peter C Appelbaum, James C Denneny, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2007
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococciCatherine Clark, Kathy Smith, Lois Ednie, et al.
The Journal of Antimicrobial Chemotherapy|December 28, 2010
Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpointSandrine Lemaire, Klaudia Kosowska-Shick, Peter C Appelbaum, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2006
Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominisKlaudia Kosowska-Shick, Kathy Smith, Tatiana Bogdanovich, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agentsDianne B Hoellman, Gengrong Lin, Lois M Ednie, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2010
Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophilaSandrine Lemaire, Klaudia Kosowska-Shick, Peter C Appelbaum, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenesKlaudia Kosowska-Shick, Catherine Clark, Kim Credito, et al.
Pageof 15